HBM Healthcare Investments AG logo

HBMN - HBM Healthcare Investments AG Share Price

CHF270.5 -3.0  -1.1%

Last Trade - 4:30pm

Sector
Financials
Size
Mid Cap
Market Cap £1.60bn
Enterprise Value £1.69bn
Revenue £349.2m
Position in Universe 293rd / 1042
Bullish
Bearish
Unlock HBMN Revenue
Momentum
Relative Strength (%)
1m +4.51%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.88%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
320.2 42.4 142.4 152.6 265.9 235.1 -6.0%
-20.8 -90.4 +509.7 -12.7 +81.6 -12.6 +28.8 -20.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 30 June 2020, HBM Healthcare Investments AG revenues increased from SF88.5M to SF267.5M. Net income increased from SF75.2M to SF225.9M. Revenues reflect Net change in value of investment in sub increase from SF81.9M to SF279.2M, Net result from shares of parent company increase from SF1.2M to SF3.8M, Dividend income increase from SF0K to SF29K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for HBMN
Graphical History

Revenue

HBMN Revenue Unlock HBMN Revenue

Net Income

HBMN Net Income Unlock HBMN Revenue

Normalised EPS

HBMN Normalised EPS Unlock HBMN Revenue

PE Ratio Range

HBMN PE Ratio Range Unlock HBMN Revenue

Dividend Yield Range

HBMN Dividend Yield Range Unlock HBMN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
HBMN EPS Forecasts Unlock HBMN Revenue
Profile Summary

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Directors
Last Annual March 31st, 2020
Last Interim June 30th, 2020
Incorporated April 9, 2001
Public Since February 14, 2008
No. of Shareholders: 2,521
No. of Employees: n/a
Sector Financials
Industry Investment Banking & Investment Services
Index
Exchange SIX Swiss Exchange
Shares in Issue 6,957,090
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HBMN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HBMN
Upcoming Events for HBMN
Frequently Asked Questions for HBM Healthcare Investments AG
What is the HBM Healthcare Investments AG share price?

As of 4:30pm, shares in HBM Healthcare Investments AG are trading at CHF270.5, giving the company a market capitalisation of £1.60bn. This share price information is delayed by 15 minutes.

How has the HBM Healthcare Investments AG share price performed this year?

Shares in HBM Healthcare Investments AG are currently trading at CHF270.5 and the price has moved by 45.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the HBM Healthcare Investments AG price has moved by 62.64% over the past year.

What are the analyst and broker recommendations for HBM Healthcare Investments AG?

Of the analysts with advisory recommendations for HBM Healthcare Investments AG, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for HBM Healthcare Investments AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will HBM Healthcare Investments AG next release its financial results?

HBM Healthcare Investments AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the HBM Healthcare Investments AG dividend yield?

HBM Healthcare Investments AG does not currently pay a dividend.

Does HBM Healthcare Investments AG pay a dividend?

HBM Healthcare Investments AG does not currently pay a dividend.

When does HBM Healthcare Investments AG next pay dividends?

HBM Healthcare Investments AG does not currently pay a dividend.

How do I buy HBM Healthcare Investments AG shares?

To buy shares in HBM Healthcare Investments AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of HBM Healthcare Investments AG?

Shares in HBM Healthcare Investments AG are currently trading at CHF270.5, giving the company a market capitalisation of £1.60bn.

Where are HBM Healthcare Investments AG shares listed? Where are HBM Healthcare Investments AG shares listed?

Here are the trading details for HBM Healthcare Investments AG:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: HBMN
What kind of share is HBM Healthcare Investments AG?

Based on an overall assessment of its quality, value and momentum, HBM Healthcare Investments AG is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a HBM Healthcare Investments AG share price forecast 2020?

Shares in HBM Healthcare Investments AG are currently priced at CHF270.5. At that level they are trading at 5.67% premium to the analyst consensus target price of 0.00.

Analysts covering HBM Healthcare Investments AG currently have a consensus Earnings Per Share (EPS) forecast of 33.83 for the next financial year.

How can I tell whether the HBM Healthcare Investments AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HBM Healthcare Investments AG. Over the past six months, the relative strength of its shares against the market has been 34.27%. At the current price of CHF270.5, shares in HBM Healthcare Investments AG are trading at 18.44% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the HBM Healthcare Investments AG PE Ratio?

The HBM Healthcare Investments AG PE ratio based on its reported earnings over the past 12 months is 5.71. The shares are currently trading at CHF270.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of HBM Healthcare Investments AG?

HBM Healthcare Investments AG's management team is headed by:

Rudolf Lanz - DRC
Heinz Riesenhuber - VCH
Benedikt Suter - SEC
Andreas Wicki - CEO
Robert Ingram - DRC
Eduard Holdener - DRC
Hans Hasler - CHM
Erwin Troxler - CFO
Mario Giuliani - DRC
Who are the major shareholders of HBM Healthcare Investments AG?

Here are the top five shareholders of HBM Healthcare Investments AG based on the size of their shareholding:

Giuliani (Mario Germano) Individual Investor
Percentage owned: 15.81% (1.10m shares)
Mirabaud Asset Management AG Investment Advisor
Percentage owned: 1.21% (84.5k shares)
Mirabaud - Equities Swiss Small and Mid Mutual Fund
Percentage owned: 1.16% (81.0k shares)
Wicki (Andreas) Individual Investor
Percentage owned: 0.77% (53.5k shares)
Tavau Swiss Fund Mutual Fund
Percentage owned: 0.57% (40.0k shares)
Similar to HBMN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.